Click here for an accessible version of this site

Symtoms

Meningococcal disease can progress rapidly, so when it comes to treatment speed is essential.3 If a person has meningococcal disease, or is suspected of having it, they need to be seen by a health-care provider immediately.

Meningococcal disease may be difficult to recognize, especially in its early stages. It has a number of symptoms that are similar to the flu (influenza), such as fever, headache, and nausea.3 This can lead to a misdiagnosis and a decision to wait it out. Unfortunately, waiting with meningococcal disease is the worst thing someone can do.

A person with meningococcal disease may have some or all of the following symptoms. And they might not experience all the symptoms at the same time:3,5

  • Severe headaches
  • High fever
  • Painfully stiff neck
  • Nausea and vomiting
  • Numbness in hands and feet
  • Light sensitivity
  • Confusion
  • Rash
  • Seizures

It is not worth taking chances with such a fast-moving and potentially deadly disease. Help protect your children today by vaccinating them with Menactra vaccine.

NEXT: How do I get the vaccine?

What’s your story?

Share your personal experience with meningococcal disease and meningitis.

Ask for Menactra vaccine today

Vaccinating your children against meningococcal disease (which includes meningitis) is the best way to help protect them.

Help for the underinsured and uninsured

If you’re underinsured or uninsured, your child can still get the Menactra vaccine – for little or no fee.13

Indication
Menactra vaccine is given to persons 2 through 55 years of age for active immunization against invasive meningococcal disease caused by N meningitidis serogroups A, C, Y, and W-135. Menactra vaccine will not stimulate protection against infection caused by N meningitidis other than serogroups A, C, Y, and W-135.

Safety Information
Side effects to Menactra vaccine include injection site pain, redness, and swelling; headache or fatigue. Other side effects may occur. Vaccination should be avoided by persons with known hypersensitivity (severe allergic reaction) to any ingredient of the vaccine, including latex (which is used in the vial stopper), or by any persons previously diagnosed with Guillain-Barré syndrome. There is a potential for an increased chance of getting Guillain-Barré syndrome following vaccination. Vaccination with Menactra vaccine may not protect all individuals.

For more information about Menactra vaccine, talk to your health-care professional.